The Patent Finder

Jiva Pharma, Inc.

8 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 12, 2027
    The maintenance fee for 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents (US 10,646,477) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

PatentTitleStatus Expires Confidence
US 9,808,497Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,364,465Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,815,777Metformin salts to treat Type2 diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,540,307Statins of omega-3 polyunsaturated acids for treating hypercholesterolemia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,688,613Omegabalins, GABA derivatives of omega-3 polyunsaturated acids, their formulations and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,646,4775-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,202,7745-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,125,078NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators
In force
 · From the USPTO record
In forceFrom the USPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited